Blog — Apr. 28, 2026

Navigating the Equity Capital Markets: IPO Market Renaissance & Structural Shifts - S&P Global’s Recent Webinar

On March 19, S&P Global Market Intelligence hosted a dynamic live session on the fast-changing equity capital markets (ECM) landscape. This timely webinar, which took place shortly after the onset of the Middle East conflict on February 28, had over 600 registrants. Moderated by myself, Patricia Medina, the event featured a panel comprised of Melissa Otto, Christopher Fenske, Thomas Mercieca, and Charlie Bovard – who provided insights into IPO trends, the rise of AI-fueled IPOs, and the overall equity capital markets outlook. For those who missed this crucial discussion or wish to revisit the key takeaways, the full webinar replay is now available and offers a deeper dive into these topics.

Key highlights

Macroeconomic Backdrop with an Uncertainty Tilt

  • In the past 10 years, the U.S Federal Reserve has managed the policy rate in the context of evolving labor and inflationary dynamics. The Fed embarked on a tightening cycle in 2022 and 2023, as the U.S Core Personal Consumption Expenditure Price (PCE) Index surpassed the 2% target.
  • Amid ongoing quantitative easing and directionally downward PCE path, the Fed eased 175 basis points from 2024 to 2025. But, clouds are gathering in early 2026. This uncertainty, compounded by geopolitical issues, presents a significant monetary policy dilemma for central banks contingent on the inflation path ahead.

Overview of Current Landscape

  • This macroeconomic setup that previously overshadowed equity issuance evolved into a rebound in both deal count and aggregate proceeds by late 2025. Global IPO activity, for instance, posted over 400 transactions per quarter in the second half of 2025, a notable increase from about 330 quarterly transactions average between Q4 2023 and Q2 2025.
  • Thomas Mercieca and Charlie Bovard provided a granular look at issuance and IPO activity across key regions: the U.S., Europe, and the Gulf Cooperation Council. They showcased the top 10 regional equity issuances in Q4 2025, with healthcare supplier Medline, Inc.'s $7.2 billion gross amount offering leading in the U.S., while industrial sector company Verisure Plc's $4.1 billion deal topping Europe. The webinar presented compelling data, including a chart plotting public common and convertible preferred equity issuances tracked by S&P Global Market Intelligence from January 1, 2021 to December 31, 2025.
Gross equity issuance activity since 2021

U.S IPO Performance Overview

  • Christopher Fenske offered a thorough analysis of IPO trends, sector, and subsector performance, emphasizing the key role of deal size in performance metrics, including first-day "pop" and the initial 60 trading days post-IPO pricing. Intriguingly, 2025 emerged as the second-highest U.S. IPO day one performance over the past decade, with 2025 U.S. IPOs increasing 27.8% by weighted average on their first day of trading.
  • Data from S&P Capital IQ Pro for the 2024–2025 period highlighted noticeable dispersion across subsectors. For example, Health Care Equipment & Supplies and Software reported the largest total net change in IPO market values, while IT Services stood out as the best performer by weighted average percentage change in price. Sector rotation was back in Q1 2026, driven by AI disruption fears in the Software sector and geopolitical concerns boosting energy producers stock prices.
IPO Market Values

Technology and AI IPOs: AI Beyond the Hype

  • Melissa Otto’s spotlight segment provided a deep dive into the burgeoning world of Technology and AI IPOs. She powerfully argued that artificial intelligence spending is no longer a niche topic. Sizeable capital expenditure for AI infrastructure, from hyperscalers’ data centers to next-generation memory hardware, is now underpinning a robust pipeline of potential tech listings.
  • The webinar replay offers a detailed capex breakdown by major hyperscalers and revised estimates for 2026 provided by Visible Alpha. Notably, in 2025, the percentage of U.S. Tech IPOs that closed up more than 30 percent on debut eclipsed their Healthcare counterparts for the first time since 2020. This section also addressed how regulatory changes, macro and microeconomic issues, and shifting investor sentiment necessitate a differentiated approach for technology firms intending to go public, especially given their rapid innovation cycles and heightened market scrutiny in early 2026.
Complex backdrop for Tech IPOs

Panel Discussion: Equity Capital Markets Outlook

  • The webinar included a dynamic panel discussion, led by myself, Patricia Medina, where the future of ECM was underscored by cautious optimism and strategic pivoting. Key topics included the path to liquidity, exit options, and the intricacies of UK/EU listing rules. Regarding liquidity, the panel consensus was that while an IPO remains a classic route, the current market demands a more flexible approach to monetization. This is the result of the significant presence of private equity sponsors and business development companies. Such context often requires a nuanced balance against the cost of capital provided by institutional backers.
  • Lastly, a live Q&A section addressed a variety of audience questions including U.S. insurance IPOs, expectations for sizeable IPOs telegraphed for the coming months, and retail vs institutional investor trends in equity markets.

Webinar Replay

  • The full 60-minute webinar replay is available now. It includes all the detailed sections covered, insightful charts, regional IPO rankings, and related research articles. You can also access the live Polling Questions with audience responses to get a real-time pulse of market sentiment. 

Learn More About Visible Alpha

Learn More About Xpressfeed™

Ready to learn more about S&P Global Market Intelligence